Combined treatment with the Hsp90 inhibitor NXD30001 and radiation dramatically prolonged median life and decreased tumor volume in mice with GBM, which resulted from the impairment of DDR by changing DDR-related protein expression [71]. Here, HSP90AB1 is linked to glioblastoma.